Please enable JavaScript to continue using this application.

Compare $MNKD vs $TRAX | Chartloom

Compare

$MNKD vs $TRAX

MannKind Corp · First Tracks Biotherapeutics Inc

MNKD

MannKind Corp

TRAX

First Tracks Biotherapeutics Inc

Compare $MNKD vs $TRAX

Comparing MannKind Corp and First Tracks Biotherapeutics Inc

MNKDMannKind Corp

TRAXFirst Tracks Biotherapeutics Inc

MNKDMannKind Corp

Market cap

$1.05B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

2.01x

Rev growth (TTM)

30.5%

YTD performance

-41.3%

52W performance

-39.5%

FCF yield

-1.7%

TRAXFirst Tracks Biotherapeutics Inc

Market cap

$1.11B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

67.6%

52W performance

67.6%

FCF yield

0.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

MNKD

TRAX

Detailed metrics comparison

MNKD

MannKind Corp

TRAX

First Tracks Biotherapeutics Inc

Market Cap

MNKD$1.05B

TRAX$1.11B

Enterprise Value

MNKD$1.57B

TRAX$943M

Price

MNKD$3.29

TRAX$31.85

P/E Ratio

MNKDN/A

TRAXN/A

P/S Ratio

MNKD2.67x

TRAX0.00x

EV/Sales

MNKD3.98x

TRAX0.00x

EV/EBITDA

MNKD43.92x

TRAX0.00x

P/B Ratio

MNKD69.42x

TRAX7.04x

P/FCF Ratio

MNKDN/A

TRAXN/A

EV/FCF

MNKD-86.45x

TRAX0.00x

PEG Ratio

MNKDN/A

TRAXN/A

Forward P/E (NTM)

MNKDN/A

TRAXN/A

Forward P/S (NTM)

MNKD2.01x

TRAXN/A

Revenue (TTM)

MNKD$394M

TRAX$0

Revenue Growth (YoY)

MNKD30.5%

TRAXN/A

Forward Rev Growth

MNKD13.7%

TRAX0.0%

Gross Margin (TTM)

MNKD76.8%

TRAX0.0%

Operating Margin (TTM)

MNKD2.3%

TRAX0.0%

EBITDA Margin (TTM)

MNKD8.7%

TRAX0.0%

Net Margin (TTM)

MNKD-10.9%

TRAX0.0%

FCF Margin (TTM)

MNKD-4.6%

TRAXN/A

Net Income (TTM)

MNKD$-43M

TRAX$-84M

FCF (TTM)

MNKD$-18M

TRAX$0

EPS (TTM)

MNKD-$0.14

TRAX-$2.40

ROE (TTM)

MNKD-29771.0%

TRAX0.0%

ROA (TTM)

MNKD-619.0%

TRAX0.0%

ROIC (TTM)

MNKD-2719.0%

TRAX0.0%

Cash

MNKD$53M

TRAX$168M

Debt

MNKD$570M

TRAX$0

Net Cash/Debt

MNKD$-517M

TRAX$168M

Current Ratio (TTM)

MNKD1.72x

TRAX14.28x

Quick Ratio (TTM)

MNKD1.29x

TRAX14.08x

Debt/Equity (TTM)

MNKD9.95x

TRAX0.00x

Debt/Assets (TTM)

MNKD0.0%

TRAX0.0%

Interest Coverage (TTM)

MNKDN/A

TRAXN/A

Net Debt/EBITDA (TTM)

MNKD0.00x

TRAX0.00x

Beta

MNKD1.09

TRAX1.60

52W Performance

MNKD-39.5%

TRAX67.6%

YTD Performance

MNKD-41.3%

TRAX67.6%

% from 52W High

MNKD-49.5%

TRAX-36.2%

% from 52W Low

MNKD47.5%

TRAX116.4%

Asset Turnover (TTM)

MNKD0.57x

TRAX0.00x

FCF Yield (TTM)

MNKD-1.7%

TRAX0.0%

Earnings Yield (TTM)

MNKD-4.1%

TRAX-7.5%

Dividend Yield (TTM)

MNKDN/A

TRAXN/A

Rule of 40

MNKD25.8

TRAX0.0

EV/GP/RG

MNKD0.15

TRAXN/A

Ticker research

View MNKD research View TRAX research

Metric	MNKD MannKind Corp	TRAX First Tracks Biotherapeutics Inc
Market & Valuation
Market Cap	$1.05B	$1.11B
Enterprise Value	$1.57B	$943M
Price	$3.29	$31.85
P/E Ratio	N/A	N/A
P/S Ratio	2.67x	0.00x
EV/Sales	3.98x	0.00x
EV/EBITDA	43.92x	0.00x
P/B Ratio	69.42x	7.04x
P/FCF Ratio	N/A	N/A
EV/FCF	-86.45x	0.00x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	2.01x	N/A
Revenue & Growth
Revenue (TTM)	$394M	$0
Revenue Growth (YoY)	30.5%	N/A
Forward Rev Growth	13.7%	0.0%
Profitability
Gross Margin (TTM)	76.8%	0.0%
Operating Margin (TTM)	2.3%	0.0%
EBITDA Margin (TTM)	8.7%	0.0%
Net Margin (TTM)	-10.9%	0.0%
FCF Margin (TTM)	-4.6%	N/A
Net Income (TTM)	$-43M	$-84M
FCF (TTM)	$-18M	$0
EPS (TTM)	-$0.14	-$2.40
ROE (TTM)	-29771.0%	0.0%
ROA (TTM)	-619.0%	0.0%
ROIC (TTM)	-2719.0%	0.0%
Financial Health
Cash	$53M	$168M
Debt	$570M	$0
Net Cash/Debt	$-517M	$168M
Current Ratio (TTM)	1.72x	14.28x
Quick Ratio (TTM)	1.29x	14.08x
Debt/Equity (TTM)	9.95x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.09	1.60
52W Performance	-39.5%	67.6%
YTD Performance	-41.3%	67.6%
% from 52W High	-49.5%	-36.2%
% from 52W Low	47.5%	116.4%
Efficiency & Yields
Asset Turnover (TTM)	0.57x	0.00x
FCF Yield (TTM)	-1.7%	0.0%
Earnings Yield (TTM)	-4.1%	-7.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	25.8	0.0
EV/GP/RG	0.15	N/A
Ticker research	View MNKD research	View TRAX research

Valuation

P/S Ratio

TRAX

0.00x

MNKD

2.67x

EV/FCF

MNKD

-86.45x

TRAX

0.00x

Growth & revenue

Revenue Growth TTM

MNKD

30.5%

Forward Revenue Growth

MNKD

13.7%

TRAX

0.0%

Profitability & performance

Gross Margin

MNKD

76.8%

TRAX

0.0%

ROE

TRAX

0.0%

MNKD

-29771.0%

FCF Yield %

TRAX

0.0%

MNKD

-1.7%

52-Week Performance

TRAX

67.6%

MNKD

-39.5%

Detailed metrics comparison

MNKD

MannKind Corp

TRAX

First Tracks Biotherapeutics Inc

Market Cap

MNKD$1.05B

TRAX$1.11B

Enterprise Value

MNKD$1.57B

TRAX$943M

Price

MNKD$3.29

TRAX$31.85

P/E Ratio

MNKDN/A

TRAXN/A

P/S Ratio

MNKD2.67x

TRAX0.00x

EV/Sales

MNKD3.98x

TRAX0.00x

EV/EBITDA

MNKD43.92x

TRAX0.00x

P/B Ratio

MNKD69.42x

TRAX7.04x

P/FCF Ratio

MNKDN/A

TRAXN/A

EV/FCF

MNKD-86.45x

TRAX0.00x

PEG Ratio

MNKDN/A

TRAXN/A

Forward P/E (NTM)

MNKDN/A

TRAXN/A

Forward P/S (NTM)

MNKD2.01x

TRAXN/A

Revenue (TTM)

MNKD$394M

TRAX$0

Revenue Growth (YoY)

MNKD30.5%

TRAXN/A

Forward Rev Growth

MNKD13.7%

TRAX0.0%

Gross Margin (TTM)

MNKD76.8%

TRAX0.0%

Operating Margin (TTM)

MNKD2.3%

TRAX0.0%

EBITDA Margin (TTM)

MNKD8.7%

TRAX0.0%

Net Margin (TTM)

MNKD-10.9%

TRAX0.0%

FCF Margin (TTM)

MNKD-4.6%

TRAXN/A

Net Income (TTM)

MNKD$-43M

TRAX$-84M

FCF (TTM)

MNKD$-18M

TRAX$0

EPS (TTM)

MNKD-$0.14

TRAX-$2.40

ROE (TTM)

MNKD-29771.0%

TRAX0.0%

ROA (TTM)

MNKD-619.0%

TRAX0.0%

ROIC (TTM)

MNKD-2719.0%

TRAX0.0%

Cash

MNKD$53M

TRAX$168M

Debt

MNKD$570M

TRAX$0

Net Cash/Debt

MNKD$-517M

TRAX$168M

Current Ratio (TTM)

MNKD1.72x

TRAX14.28x

Quick Ratio (TTM)

MNKD1.29x

TRAX14.08x

Debt/Equity (TTM)

MNKD9.95x

TRAX0.00x

Debt/Assets (TTM)

MNKD0.0%

TRAX0.0%

Interest Coverage (TTM)

MNKDN/A

TRAXN/A

Net Debt/EBITDA (TTM)

MNKD0.00x

TRAX0.00x

Beta

MNKD1.09

TRAX1.60

52W Performance

MNKD-39.5%

TRAX67.6%

YTD Performance

MNKD-41.3%

TRAX67.6%

% from 52W High

MNKD-49.5%

TRAX-36.2%

% from 52W Low

MNKD47.5%

TRAX116.4%

Asset Turnover (TTM)

MNKD0.57x

TRAX0.00x

FCF Yield (TTM)

MNKD-1.7%

TRAX0.0%

Earnings Yield (TTM)

MNKD-4.1%

TRAX-7.5%

Dividend Yield (TTM)

MNKDN/A

TRAXN/A

Rule of 40

MNKD25.8

TRAX0.0

EV/GP/RG

MNKD0.15

TRAXN/A

Ticker research

View MNKD research View TRAX research

Metric	MNKD MannKind Corp	TRAX First Tracks Biotherapeutics Inc
Market & Valuation
Market Cap	$1.05B	$1.11B
Enterprise Value	$1.57B	$943M
Price	$3.29	$31.85
P/E Ratio	N/A	N/A
P/S Ratio	2.67x	0.00x
EV/Sales	3.98x	0.00x
EV/EBITDA	43.92x	0.00x
P/B Ratio	69.42x	7.04x
P/FCF Ratio	N/A	N/A
EV/FCF	-86.45x	0.00x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	2.01x	N/A
Revenue & Growth
Revenue (TTM)	$394M	$0
Revenue Growth (YoY)	30.5%	N/A
Forward Rev Growth	13.7%	0.0%
Profitability
Gross Margin (TTM)	76.8%	0.0%
Operating Margin (TTM)	2.3%	0.0%
EBITDA Margin (TTM)	8.7%	0.0%
Net Margin (TTM)	-10.9%	0.0%
FCF Margin (TTM)	-4.6%	N/A
Net Income (TTM)	$-43M	$-84M
FCF (TTM)	$-18M	$0
EPS (TTM)	-$0.14	-$2.40
ROE (TTM)	-29771.0%	0.0%
ROA (TTM)	-619.0%	0.0%
ROIC (TTM)	-2719.0%	0.0%
Financial Health
Cash	$53M	$168M
Debt	$570M	$0
Net Cash/Debt	$-517M	$168M
Current Ratio (TTM)	1.72x	14.28x
Quick Ratio (TTM)	1.29x	14.08x
Debt/Equity (TTM)	9.95x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.09	1.60
52W Performance	-39.5%	67.6%
YTD Performance	-41.3%	67.6%
% from 52W High	-49.5%	-36.2%
% from 52W Low	47.5%	116.4%
Efficiency & Yields
Asset Turnover (TTM)	0.57x	0.00x
FCF Yield (TTM)	-1.7%	0.0%
Earnings Yield (TTM)	-4.1%	-7.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	25.8	0.0
EV/GP/RG	0.15	N/A
Ticker research	View MNKD research	View TRAX research